5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI

Sayanta Dutta, Lilesh Kumar Pradhan, Jie Chen, Nian Wang, Xiang Gao, Arupratan Das

Open source

DOI
10.64898/2026.10.11.758371
Published
2026-10-12
Container
Not recorded
Publisher
openRxiv
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.11.758371,
  title = {5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI},
  author = {Sayanta Dutta and Lilesh Kumar Pradhan and Jie Chen and Nian Wang and Xiang Gao and Arupratan Das},
  year = {2026},
  doi = {10.64898/2026.10.11.758371},
  url = {https://doi.org/10.64898/2026.10.11.758371}
}

RIS

TY  - JOUR
TI  - 5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI
AU  - Sayanta Dutta
AU  - Lilesh Kumar Pradhan
AU  - Jie Chen
AU  - Nian Wang
AU  - Xiang Gao
AU  - Arupratan Das
PY  - 2026
DO  - 10.64898/2026.10.11.758371
UR  - https://doi.org/10.64898/2026.10.11.758371
ER  - 

APA

Dutta, S., Pradhan, L. K., Chen, J., Wang, N., Gao, X., & Das, A. (2026). 5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI. https://doi.org/10.64898/2026.10.11.758371

Source records